Published in Lancet on April 29, 1989
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ (1993) 2.70
Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 2.38
Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. Thorax (1996) 2.29
Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax (2009) 2.12
Brittle asthma. Thorax (1998) 1.77
Fenoterol and fatal asthma. Lancet (1990) 1.77
Randomised placebo controlled trial of beta agonist dose reduction in asthma. Thorax (1999) 1.68
Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned? Thorax (1995) 1.50
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study. Lancet Respir Med (2014) 1.48
Data sharing: not as simple as it seems. Environ Health (2011) 1.40
Asthma deaths in New Zealand. BMJ (1992) 1.38
Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline. Thorax (1992) 1.21
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. Postgrad Med J (1990) 1.18
Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. Thorax (1995) 1.14
Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients. Thorax (1995) 1.12
Why are hospital admission and mortality rates for childhood asthma higher in New Zealand than in the United Kingdom? Thorax (1990) 1.09
Treatment of adult asthma: is the diagnosis relevant? Thorax (1989) 1.08
Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study. Thorax (2002) 1.06
Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Thorax (1997) 1.03
Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2012) 0.98
Interactions between corticosteroids and beta agonists. Thorax (2000) 0.97
Asthma deaths in New Zealand. BMJ (1992) 0.96
Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study. Br J Clin Pharmacol (2009) 0.95
Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax (1994) 0.95
The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis. NPJ Prim Care Respir Med (2015) 0.95
Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance? Br J Clin Pharmacol (1992) 0.92
Beta 2 agonists and asthma. BMJ (1991) 0.89
Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. CMAJ (1995) 0.87
Beta-Adrenergic Agonists. Pharmaceuticals (Basel) (2010) 0.87
Informal medicine: ethical analysis. J Med Ethics (2005) 0.87
Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action. Br J Pharmacol (2010) 0.86
Effect of regular terbutaline on the airway response to inhaled budesonide. Thorax (1996) 0.86
The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. Thorax (1991) 0.86
Salmeterol and cytokines modulate inositol-phosphate signalling in human airway smooth muscle cells via regulation at the receptor locus. Respir Res (2007) 0.85
Evaluating prognostic factors: implications for measurement of health care outcome. J Epidemiol Community Health (1992) 0.85
Asthma and the beta agonist debate. Thorax (1995) 0.85
The myocardial effects of fenoterol, isoprenaline and salbutamol in normoxic and hypoxic sheep. Int J Exp Pathol (1994) 0.84
Enhancement of airway reactivity to histamine by isoprenaline and related beta-adrenoceptor agonists in the guinea-pig. Br J Pharmacol (1993) 0.84
Cardiovascular effects of fenoterol under conditions of hypoxaemia. Thorax (1992) 0.84
Do bronchodilators adversely affect the prognosis of bronchial hyperresponsiveness? Thorax (1993) 0.82
Safety of β2-Agonists in Asthma: Linking Mechanisms, Meta-Analyses and Regulatory Practice. AAPS J (2015) 0.82
Chronic asthma. BMJ (2001) 0.81
A pilot study of polymorphism of adrenergic Beta-2 receptor and mild asthma: a clinical and pharmacogenetic study. Iran J Pharm Res (2013) 0.80
Asthma mortality: the worldwide response. J R Soc Med (1997) 0.79
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 0.79
The dose-response effects of terbutaline on the variability, approximate entropy and fractal dimension of heart rate and blood pressure. Br J Clin Pharmacol (1998) 0.77
Risk/benefit ratio of long-term treatment with beta 2-adrenoceptor agonists. Lung (1990) 0.76
Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study. Br J Gen Pract (1995) 0.76
Studies on the bronchodilator, tremorogenic, cardiovascular and hypokalaemic effects of fenoterol dry powder in asthma. Br J Clin Pharmacol (1993) 0.75
The role of platelet activating factor in allergic respiratory disease. Br J Clin Pharmacol (1990) 0.75
Development of a replicated database of DHCP data for evaluation of drug use. J Am Med Inform Assoc (1996) 0.75
Risk of severe life threatening asthma. Thorax (1996) 0.75
Asthma in adults. BMJ Clin Evid (2010) 0.75
Bronchodilator treatment in asthma and bronchitis. BMJ (1994) 0.75
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2012) 0.75
Deaths certified as asthma and use of medical services: a national case-control study. Thorax (2005) 0.75
Bronchodilators: wrong for the lung in the long run? Br J Gen Pract (1993) 0.75
Aerosol delivery systems for bronchial asthma. Postgrad Med J (1996) 0.75
The SMART study. Can Fam Physician (2007) 0.75
Asthma morbidity and mortality in New Zealand. Thorax (1995) 0.75
Asthma in adults. BMJ Clin Evid (2011) 0.75
Long-acting bronchodilators: time for a re-think. J R Soc Med (2006) 0.75
Trends in hospital admissions for asthma in Lombardy, Italy, 1976-86. J Epidemiol Community Health (1992) 0.75
Inhaled β2-agonists in asthma management: an evolving story. Breathe (Sheff) (2016) 0.75
Cardiopulmonary interactions of salbutamol and hypoxaemia in healthy young volunteers. Br J Clin Pharmacol (1995) 0.75
Bronchial asthma and the role of beta 2-agonists. Lung (1990) 0.75
Clinical management of asthma in the 1990s. Current therapy and new directions. Drugs (1996) 0.75
Trends in asthma mortality in Italy and Spain, 1980-1996. Eur J Epidemiol (2001) 0.75
Rise and fall of asthma-related mortality in Italy and sales of beta2-agonists, 1980-1994. Eur J Epidemiol (2000) 0.75
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer (2009) 5.10
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods (1991) 4.64
Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. Br Med J (Clin Res Ed) (1984) 4.46
Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology (1997) 4.35
Decisions near the end of life: professional views on life-sustaining treatments. Am J Public Health (1993) 4.27
A case-control study of deaths from asthma. Thorax (1986) 3.97
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart (2008) 3.73
Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Non-eosinophilic asthma: importance and possible mechanisms. Thorax (2002) 3.53
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34
Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg (2003) 3.32
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15
Myxomatosis. N Z Vet J (1985) 3.12
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
How much asthma is really attributable to atopy? Thorax (1999) 3.04
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
Role of methionine in the initiation of haemoglobin synthesis. Nature (1970) 3.02
COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97
Guidelines for clinical guidelines. BMJ (1998) 2.96
World War I may have allowed the emergence of "Spanish" influenza. Lancet Infect Dis (2002) 2.88
Impact of relational coordination on quality of care, postoperative pain and functioning, and length of stay: a nine-hospital study of surgical patients. Med Care (2000) 2.87
Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative. Ann Rheum Dis (2005) 2.76
The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med (1991) 2.61
Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet (1995) 2.52
Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol (1990) 2.46
Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax (1996) 2.46
Effect of environmental factors on risk of injury of child pedestrians by motor vehicles: a case-control study. BMJ (1995) 2.41
Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36
Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA (1976) 2.32
The lines of Blaschko: a review and reconsideration: Observations of the cause of certain unusual linear conditions of the skin. Br J Dermatol (1976) 2.28
Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27
The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol (2001) 2.27
Investigation of benefits and costs of an ophthalmic outreach clinic in general practice. Br J Gen Pract (1995) 2.26
Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol (1988) 2.25
Changing sex ratio in the United States, 1969-1995. Fertil Steril (1998) 2.23
Prevalence and etiology of asthma. J Allergy Clin Immunol (2000) 2.19
Passive smoking and passive thinking. N Z Med J (1989) 2.17
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Guidelines on preventing cardiovascular disease in clinical practice. BMJ (2000) 2.15
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med (1990) 2.04
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med (1994) 2.01
Explaining trends in coronary heart disease hospitalisations in New Zealand: trend for admissions and incidence can be in opposite directions. Heart (2008) 2.00
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
The role of driver sleepiness in car crashes: a systematic review of epidemiological studies. Accid Anal Prev (2001) 1.98
Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Alcohol, cardiovascular diseases and all causes of death: a review of the epidemiological evidence. Drug Alcohol Rev (1992) 1.93
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
Defining asthma in epidemiological studies. Eur Respir J (1999) 1.88
Does environmental endotoxin exposure prevent asthma? Thorax (2002) 1.88
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
Nevoid basal cell carcinoma syndrome. Can Med Assoc J (1971) 1.87
Occupational asthma in New Zealanders: a population based study. Occup Environ Med (1997) 1.84
Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy (2007) 1.81
The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79
The ecological fallacy strikes back. J Epidemiol Community Health (2000) 1.79
Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78
Latency analysis in occupational epidemiology. Arch Environ Health (1990) 1.77
Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia (2011) 1.76